DIFFERENTIAL NF-??B AND I??B GENE EXPRESSION DURING DEVELOPMENT OF CARDIAC ALLOGRAFT REJECTION VERSUS CD154 MONOCLONAL ANTIBODY-INDUCED TOLERANCE1
Authors:
- Wei GaoWGWei Gao
- Saege A. HancockSHSaege A. Hancock
- James B. RottmanJRJames B. Rottman
- Zihao WuZWZihao Wu
- Laurence A. TurkaLTLaurence A. Turka
- Ulrich SiebenlistUSUlrich Siebenlist
- Wayne W. HancockWHWayne W. Hancock
- 1 April 2001
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 71 (7) , 835-840
Abstract
The Rel/NF-kappaB transcription factor pathway, regulated by IkappaB proteins, is considered central to immune responses, although there are surprisingly few in vivo data concerning alloresponses. We undertook analysis of NF-kappaB and IkappaB mRNA intracardiac allograft expression, and NF-kappaB nuclear translocation, during acute rejection versus CD154 monoclonal antibody (mAb)-induced tolerance induction in fully MHC-disparate mice. Intragraft expression of all nine NF-kappaB and IkappaB genes increased during development of rejection, and nuclear translocation of p50, p52, and p65 was detected. CD154 mAb therapy decreased mRNA levels of all nine NF-kappaB and IkappaB genes, and impaired nuclear translocation of p50, p52, and p65 NF-kappaB proteins. However, prolonged survival could not be induced by CD154 mAb in p50- or p52-deficient allograft recipients, indicating an absolute requirement for expression of these genes in CD154 mAb-induced tolerance. We conclude that, whereas blanket approaches to NF-kappaB suppression are unlikely to be effective strategies for tolerance induction, a better understanding of the roles of individual NF-kappaB and IkappaB genes may allow development of more precise and effective therapies.Keywords
This publication has 20 references indexed in Scilit:
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genesNature Medicine, 1998
- MYOCARDIAL NUCLEAR FACTOR-??B ACTIVITY AND NITRIC OXIDE PRODUCTION IN REJECTING CARDIAC ALLOGRAFTS1Transplantation, 1998
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- I kappa B epsilon, a novel member of the IκB family, controls RelA and cRel NF‐κB activityThe EMBO Journal, 1997
- The New Genomics: Global Views of BiologyScience, 1996
- The Complete Exon-Intron Structure of the 156-kb Human Gene NFKB1, Which Encodes the p105 and p50 Proteins of Transcription Factors NF-κB and IκB-γ: Implications for NF-κB-Mediated Signal TransductionGenomics, 1995
- IκB-β regulates the persistent response in a biphasic activation of NF-κBCell, 1995
- Genomic organization of the gene encoding the p65 subunit of NF-xB: multiple variants of the p65 protein may be generated by alternative splicingHuman Molecular Genetics, 1993
- RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.Molecular and Cellular Biology, 1992